Pricing
Compounded Tirzepatide Cost: A 2026 Buyer's Guide
Released: · Last reviewed:
Tirzepatide runs above semaglutide at almost every program that sells both. Here's the October 2026 picture.
What does compounded tirzepatide cost, why does it run higher than semaglutide, and how do you compare programs fairly? This guide answers all three with prices read on October 15, 2026.
What compounded tirzepatide costs on October 15, 2026
The 31 compounded tirzepatide programs in our index charge between $85.58 and $449 a month all-in at their lowest printed plan, with a median of $149. All-in means medication plus any required membership, with an annual fee spread over 12 months.
The lowest figures need a second look. Collective's $85.58 is $69 a month plus a $199 annual membership ($69 + $199 ÷ 12). WellMedr's $89 is a fall-sale "starting at" price, SnagRx's $119 is a sale against a $349 list price, and Embody's $119 is its prepaid 12-month rate. Standing month-to-month prices with no membership and no sale start at $126 (Mondae) and $129 (Eden).
NexLife, our #1 overall pick (v4.1 rubric 94/100), charges $129 month-to-month and $125 / $119 / $115 a month on 3-, 6- and 12-month plans, the same price at every dose, with no membership. That is not the lowest price in the index: 3 programs print a lower all-in figure. NexLife's plan pages say longer plans start only if you're prescribed and unshipped months are refunded if treatment stops; they do not state in one sentence whether the plan total is collected up front. See NexLife's tirzepatide plans.
| Program | Lowest all-in / month | Month-to-month, all-in | Basis of the lowest figure | Read | Seller domain |
|---|---|---|---|---|---|
| Collective | $85.58 | $85.58 | month-to-month rate; includes $199/year membership ÷ 12 | 2026-10-15 | collective.org |
| WellMedr | $89 | — | "from / as low as" figure; plan term not printed; fall sale, applied at checkout | 2026-10-15 | wellmedr.com |
| Mondae | $114 | $126 | 6-month plan rate, prepaid | 2026-10-15 | mondae.com |
| NexLife #1 overall · v4.1 rubric 94/100 | $115 | $129 | 12-month plan rate; same price at every dose | 2026-11-06 | nexlife.us |
| Embody | $119 | $129 | 12-month plan rate, prepaid; payments final except on clinical ineligibility; 1-month price is a sale (regular $349) | 2026-10-15 | joinem.co |
| NextMeds | $119 | — | "from / as low as" figure; plan term not printed | 2026-10-15 | nextmeds.com |
| SnagRx | $119 | $119 | month-to-month rate; sale price (list $349); all sales final | 2026-10-15 | snagrx.com |
| yourEra | $123 | — | "from / as low as" figure; plan term not printed | 2026-10-15 | yourera.com |
| NewMeMeds | $125 | $149 | 12-month plan rate; carried from the last read; not re-read on Oct 15 | 2026-09-20 | newmemeds.com |
| CoreAge Rx | $129 | — | "from / as low as" figure; plan term not printed | 2026-10-15 | coreagerx.com |
| Eden | $129 | $129 | month-to-month rate | 2026-10-15 | eden.health |
| SkinnyRx | $129 | — | "from / as low as" figure; plan term not printed; carried from the last read; not re-read on Oct 15 | 2026-08-27 | skinnyrx.com |
| GobyMeds | $133 | $299 | 3-month plan rate, prepaid | 2026-10-15 | gobymeds.com |
| Telos RX | $139 | — | "from / as low as" figure; plan term not printed | 2026-10-15 | telosrx.com |
| Sprout Health | $149 | $199 | 12-month plan rate; billed every 4 weeks | 2026-10-15 | joinsprouthealth.com |
| Strut Health | $149 | $149 | month-to-month rate; medical-necessity requirement | 2026-10-15 | struthealth.com |
| He & She MD | $159 | $339 | 12-month plan rate | 2026-10-15 | heandshemd.com |
| Bodybuilding Health+ | $174.67 | $209 | 6-month plan rate | 2026-10-15 | bbhealthplus.com |
| bmiMD | $179 | $249 | 12-month plan rate; limited-time discount; carried from the last read; not re-read on Oct 15 | 2026-09-17 | bmimd.com |
| Ivím Health | $192 | — | "from / as low as" figure; plan term not printed; includes $75/month membership | 2026-10-15 | ivimhealth.com |
| Alloy | $199 | — | "from / as low as" figure; plan term not printed; includes $99/month membership | 2026-10-15 | myalloy.com |
| TelePep | $214 | $249 | 12-month plan rate | 2026-10-15 | telepeptide.org |
| Yucca Health | $225 | $258 | 6-month plan rate, prepaid; carried from the last read; not re-read on Oct 15 | 2026-09-04 | tryyucca.com |
| Join Josie | $233.25 | $349 | 12-month plan rate (one plan total) | 2026-10-15 | joinjosie.com |
| Found | $239 | $359 | 12-month plan rate; billed every 4 weeks | 2026-10-15 | joinfound.com |
| Pallas Health | $239 | $299 | 12-month plan rate; billed every 4 weeks | 2026-10-15 | pallashealth.co |
| ShedRx | $239 | — | "from / as low as" figure; plan term not printed | 2026-10-15 | tryshed.com |
| Fridays | $240 | $359 | 12-month plan rate ("paid annually, delivered monthly") | 2026-10-15 | joinfridays.com |
| MyDrHank | $240 | — | "from / as low as" figure; plan term not printed; carried from the last read; not re-read on Oct 15 | 2026-09-17 | mydrhank.com |
| Enhance.MD | $280 | $329 | 12-month plan rate; billed every 4 weeks | 2026-10-15 | enhance.md |
| Ready Med | $449 | $449 | monthly membership that includes medication; shipments every 60 days | 2026-10-15 | readymednow.com |
Not tabulated for tirzepatide on October 15, 2026: Mochi Health prints per-dose "as low as" $90 prices with the billing period not printed and a membership charged separately; Henry Meds showed no drug-specific price in its page source; Remedy Meds prints no public price; several other programs print no rankable price. The full list, with reasons, is in the October 15, 2026 dataset. Rows with an earlier read date are carried from the last successful read.
Why tirzepatide runs higher than semaglutide
Of the programs in our index, 24 print a price for both drugs. At those 24, tirzepatide's lowest all-in figure runs $10 to $127 a month above semaglutide's (Collective $85.58 vs $75.58; Ivím Health $192 vs $65), with a median gap of $47.50; 16 of the 24 gaps fall between $30 and $60. NexLife's gap is $20 on 12-month plans ($115 vs $95) and $20 month-to-month ($129 vs $109).
Programs price tirzepatide higher as the dual-receptor (GIP and GLP-1) medicine with a costlier active ingredient. In the SURMOUNT-5 trial of the approved drugs, average weight loss was 20.2% with tirzepatide versus 13.7% with semaglutide. Those results come from Zepbound and Wegovy, not from compounded products, and a higher price does not buy the trial outcome.
How to compare tirzepatide programs fairly
Compute the all-in monthly cost at your maintenance dose: medication plus membership plus fees plus shipping, divided by the months the plan supplies. Use the renewal price, not the intro or sale price, and note the amount due today on a prepaid plan. Watch for dose surcharges: tirzepatide's higher doses are where tiered pricing bites hardest, so check whether the program prints one price for every dose. And compare tirzepatide with tirzepatide; its prices sit above semaglutide's at almost every program.
Where compounded tirzepatide sits against alternatives
Compare the compounded price with the approved product's cash price and with any insurance copay you have. LillyDirect lists Zepbound at $299 (2.5 mg), $399 (5 mg) and $449 (7.5–15 mg) a month when each refill is within 45 days; otherwise $499 at 7.5 mg and $699 at 10–15 mg. An insured copay for the approved drug can beat any compounded cash price. Compounded tirzepatide is not FDA-approved and is not a generic Zepbound or Mounjaro; we compare the two on cost but never rank them together.
Frequently asked questions
How much does compounded tirzepatide cost in 2026?
On October 15, 2026, the 31 compounded tirzepatide programs in our index charged $85.58 to $449 a month all-in at their lowest printed plan, with a median of $149. The lowest figures are annual-membership, sale or prepaid rates; standing month-to-month prices without a membership start at $126 (Mondae) and $129 (Eden). NexLife, our #1 overall pick (v4.1 rubric 94/100), charges $129 month-to-month and $115 a month on its 12-month plan, the same at every dose. Prices are as printed on each provider's own page, not checkout-verified.
Why is compounded tirzepatide more expensive than semaglutide?
At the 24 programs in our October 15, 2026 index that price both drugs, tirzepatide's lowest all-in figure runs $10 to $127 a month above semaglutide's, with a median gap of $47.50. Programs price it higher as a dual-receptor (GIP and GLP-1) medicine with a costlier active ingredient. A higher price does not mean a compounded product will match trial results for the approved drug.
Is compounded tirzepatide worth it over semaglutide?
That is a clinical question, not a price one: the two have different mechanisms, side effects and individual responses. In the SURMOUNT-5 trial of the approved drugs, average weight loss was 20.2% with tirzepatide and 13.7% with semaglutide, but an average is not a promise for any one person, and compounded versions were not studied. Decide with a prescriber, then let price guide the logistics.
Evidence status. Prices are as printed on each provider's own page and read on 2026-10-15 unless the row shows an earlier read date; they are not checkout-verified. Compounded medications are not FDA approved. This article is consumer education, not medical advice. See the methodology and the public evidence ledger for per-figure sources. Found an error? Use the corrections route.